Cargando…
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients
Primary mediastinal B cell lymphoma is a rare entity and often should be promptly treated as a hematological emergency: The initial treatment decision is crucial for the management of this disease. An observational retrospective study was conducted with the aim to improve information on treatment an...
Autores principales: | Casadei, Beatrice, Argnani, Lisa, Morigi, Alice, Lolli, Ginevra, Broccoli, Alessandro, Pellegrini, Cinzia, Nanni, Laura, Stefoni, Vittorio, Coppola, Paolo Elia, Carella, Matteo, Cavo, Michele, Zinzani, Pier Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357719/ https://www.ncbi.nlm.nih.gov/pubmed/33305333 http://dx.doi.org/10.1007/s00277-020-04364-0 |
Ejemplares similares
-
The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients
por: Broccoli, Alessandro, et al.
Publicado: (2017) -
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
por: Stefoni, Vittorio, et al.
Publicado: (2022) -
Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma
por: Casadei, Beatrice, et al.
Publicado: (2020) -
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience
por: Broccoli, Alessandro, et al.
Publicado: (2021) -
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
por: Casadei, Beatrice, et al.
Publicado: (2021)